You are here

bankruptcy

Troubled poop-testing startup uBiome announces plans for liquidation

Troubled poop-testing startup uBiome announces plans for liquidation

Endpoints

Flag link:

Amryt buys Aegerion via bankruptcy, adding sales to support R&D

Amryt buys Aegerion via bankruptcy, adding sales to support R&D

Fierce Biotech

Flag link:

Facing $4B in claims, Insys doubts ability to pay out via Chapter 11

Facing $4B in claims, Insys doubts ability to pay out via Chapter 11

Biopharma Dive

INSYS Therapeutics

Flag link:

Embattled Purdue Pharma asks judge to authorize $34M in employee bonuses

Embattled Purdue Pharma asks judge to authorize $34M in employee bonuses

The Hill

Flag link:

Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial

Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial

BioSpace

Sienna Biopharmaceuticals

Flag link:

Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy

Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy

Stat

Flag link:

Purdue talks may have stalled with state AGs, but cities and counties are still at it: AP

Purdue talks may have stalled with state AGs, but cities and counties are still at it: AP

Fierce Pharma

Flag link:

Purdue preps bankruptcy as opioid settlement bid stumbles; report

Purdue preps bankruptcy as opioid settlement bid stumbles; report

Pharmaforum

Flag link:

Mallinckrodt preps a possible bankruptcy amid a maelstrom of opioid claims — report

Mallinckrodt preps a possible bankruptcy amid a maelstrom of opioid claims — report

Endpoints

Flag link:

Bankrupt uBiome Says Founders May Have Misled Investors

Bankrupt uBiome Says Founders May Have Misled Investors

Xconomy

Flag link:

States Pause Lawsuits Against Insys During Bankruptcy Proceedings

States Pause Lawsuits Against Insys During Bankruptcy Proceedings

BioSpace

INSYS Therapeutics

Flag link:

Insys Therapeutics Files for Bankruptcy Following Legal Trouble

Insys Therapeutics Files for Bankruptcy Following Legal Trouble

BioSpace

INSYS Therapeutics

Flag link:

Achaogen’s bankruptcy and going-out-of-business sale offer a grim cautionary tale for the future of antibiotic development

Achaogen’s bankruptcy and going-out-of-business sale offer a grim cautionary tale for the future of antibiotic development

Endpoints

drug development

Flag link:

Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval

Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval

Xconomy

Flag link:

If Purdue Pharma declares bankruptcy, what would it mean for lawsuits against the opioid manufacturer?

If Purdue Pharma declares bankruptcy, what would it mean for lawsuits against the opioid manufacturer?

Stat

Flag link:

Throwing in the towel, troubled antibiotic maker Aradigm files for Chapter 11

Throwing in the towel, troubled antibiotic maker Aradigm files for Chapter 11

Endpoints

Flag link:

To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

Xconomy

Synergy Pharmaceuticals

Flag link:

What We Can Learn From Synergy Pharmaceuticals' Disastrous News

What We Can Learn From Synergy Pharmaceuticals' Disastrous News

Motley Fool

Synergy Pharmaceuticals

Flag link:

Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale

Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale

Xconomy

Flag link:

Who made lots of money from this biotech bankruptcy? Hint: It wasn't Martin Shkreli

Who made lots of money from this biotech bankruptcy? Hint: It wasn't Martin Shkreli

Bizjournals.com

Flag link:

Pages